THE HAGUE, Netherlands (AP) – The Dutch government announced on Friday that it was temporarily suspending the AstraZeneca coronavirus vaccine for people under the age of 60 following reports that very few people had unusual blood clots after receiving a shot.
The decision by the Netherlands came three days after German authorities also discontinued the AstraZeneca vaccine until the 1960s, citing new concerns about unusual blood clots in a small number of recipients.
Earlier in the day, a Dutch vaccine side effects watchdog said it had received five low-blood transfusions after vaccination. All cases occurred within seven to 10 days of vaccination. are:
The organization said that about 400,000 people were vaccinated with AstraZeneca in the Netherlands during the reporting of five cases.
Health Minister Hugo de Jong says the suspension is a precautionary measure.
“I think it is very important that the Dutch reports are also properly studied,” said De Jong. “You have to be careful with caution.”
The news is another step back from the AstraZeneca vaccine, which is crucial in Europe’s immunization campaign – a key part of the global recruitment strategy for poor countries, as it is cheaper and easier to use than Pfizer և Moderna’s competitors. It comes from the EU drug regulator two weeks after the vaccine did not increase the overall incidence of blood clots after such fears.
The European Medicines Agency said at the time that the benefits of the vaccine outweighed the risks, but that this could not rule out a link between the shot and some unusual blood clots, and advised raising the risk of rare side effects.
Many EU countries, including Germany, resumed use of the AstraZeneca vaccine on March 19.
De Jong said the Dutch break comes next week before the EU drug agency updates on the AstraZeneca vaccine.
Keep track of AP epidemic coverage time